Who is the CEO of Cutia Therapeutics?

The CEO of Cutia Therapeutics is Lele Zhang.

What industry does Cutia Therapeutics belong to?

Cutia Therapeutics operates in the Biotechnology industry within the Healthcare sector.

Where is Cutia Therapeutics headquartered?

Cutia Therapeutics is headquartered at Huanzhi Building, Shanghai, 200070, CN.

What is the IPO date of Cutia Therapeutics?

Cutia Therapeutics went public on June 12, 2023.

How many employees does Cutia Therapeutics have?

Cutia Therapeutics has approximately 333 full-time employees.

Cutia Therapeutics

2487.HK•HKSE

Healthcare

Biotechnology

HK$8.52

HK$-0.25(-2.85%)

Cutia Therapeutics (2487.HK) Company Profile & Overview

Explore Cutia Therapeutics’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Cutia Therapeutics (2487.HK) Company Profile & Overview

Cutia Therapeutics operates as a biopharmaceutical company that develops a dermatology platform for skin and scalp diseases. The company focuses on the dermatology treatment and care therapeutic areas, including localized adipose accumulation management medication, scalp diseases and care, skin diseases and care, and topical anesthesia. The company was incorporated in 2019 and is based in Shanghai, China with additional offices in Beijing, Wuxi and Hong Kong.

SectorHealthcare

IndustryBiotechnology

CEOLele Zhang

Contact Information

https://www.cutiatx.com

86 21 5298 2688

Huanzhi Building, Shanghai, 200070

Company Facts

333 Employees

IPO DateJun 12, 2023

CountryCN

Actively Trading

Frequently Asked Questions

;